University of Barcelona

Information for the student – Advanced Immunology

Practices and Master's Thesis (TFM) 2024-2025

Receiving groups

AREAS

It is understood that the Master's Final Project (TFM) in Immunology must give great importance to the training of the student in the field of learning laboratory techniques, to know how to apply experimental design, to know how to use and benefit from the results. This involves establishing a working hypothesis capable of designing an experiment and, finally, how to interpret the results and present them correctly in order to explain and discuss them with the scientific community. In any of the profiles, students will develop a specific project throughout the academic year that will consist of 24 ECTS. The work will be closely supervised by the tutor who will control the development of the work. Before starting, the work must specify the main objective and the development of the experiments to be carried out by the student. The experimental phase of the work must be complemented with a time of literature review according to the tutor's criteria. In the final phase, the student will write the work in the usual format of 1) the introduction, 2) objectives, 3) the materials and methods, 4) results, 5) discussion, 6) conclusions, 7) bibliography, following the regulations of the Master's Committee. The work is presented and defended, orally, before a committee, whose members are selected by the Master's Committee. The general provisions applicable tothe Master's Thesis can be found at  http://www.giga.ub.edu/acad/gdoc/fitxers/pdf/normes_TFM.pdf
Lines of research for which it has been confirmed that they offer a place to do the TFM in the 2024-25 academic year
Groups that cannot accept master's students in the 2024-25 academic year

UB – Barcelona Science Park (PCB)
Translational immunology in chronic human inflammation.
Dr. Lluis Santamaría, Professor of Immunology, Tel. 93 4031160. Email: lfsantama@gmail.com
Metabolic Interaction in the Tumor Microenvironment.
Dr. Carlos Sebastián, Associate Professor, Tel. 93 4037166 . Email: csebastian@ub.edu

UB - Faculty of Biology
Innate lymphocytes and autoimmunity.
Dr. Raquel Planas, Prof. Lecturer, Email: raquel.planas@ub.ed

UB - Faculty of Medicine and Health Sciences - Hospital Clínic
Immunoreceptors.
Dr. Pablo Engel, Full Professor, Tel. 93 2275400 (ext. 4010). Email: pengel@ub.edu
Viral immunoevasion.
Dr. Ana Angulo, Associate Professor, Tel. 93 2275400 (ext. 4015). Email: aangulo@ub.edu
Recipients of innate immunity.
Dr. Francisco Lozano, Full Professor, Tel. 93 2275488. Email: flozano@clinic.cat

Chimeric antigen receptors and immunotherapy of leukaemias and lymphomas (CART19).
Dr. Manel Juan, Head of the Immunotherapy Section, Tel. 93 2275463. Email: mjuan@clinic.cat
Cellular immunotherapy for the prevention and treatment of kidney transplant rejection.
Dr. Eduard Palou, Specialist Physician, Dept. of Immunology, Hospital Clínic, Tel. 93 2273429. Email: epalou@clinic.cat

Study of the immunostimulatory capacity of nanoparticles in human dendritic cells.
Dr. Daniel Benítez, Researcher, Dept. of Immunology, Hospital Clínic, Email: dbenitezr@clinic.cat

Modulators of the immune response. Characterization of new molecules involved in anaphylaxis.
Dr. Margarita Martín Andorra, Associate Professor, Tel. 93 4020582. Email: martin_andorra@ub.edu

Small RNAs as inflammation inducers in Huntington's disease.
Dr. Eulàlia Martí, Associate Professor. Tel. 93 4035278 Email: eulalia.marti@ub.edu

Host-microbiota interaction in Crohn's disease using integrative multiomics: from systems immunology to antibody engineering.
Dr. Giuliana Magri, Ramón y Cajal Researcher. Email: gmagri@ub.edu

Alterations of the immune system in ischemic pathology.
Dr. Anna Planas, Associate Professor, tel. 93 3638327. Email: anna.planas@ub.edu

 

UB - IDIBAPS - Hospital Clínic
Gene regulation in stem cells, cell plasticity, differentiation and cancer.
Dr. Antonio Postigo, ICREA Researcher, Tel. 93 2279170. Email:idibaps.postigo3@gmail.com

Bronchial infection and immunity to chronic respiratory diseases.
Dr. Rosa Faner, FIS Researcher, Tel. 93 2271789. Email: rfaner@clinic.cat

Mechanisms of self-regulation in autoimmune diseases.
Dr. Pere Santamaria, Researcher IDIBAPS/University of Calgary, Tel. . Email: PESANTAM@clinic.cat
Dr. Pau Serra, IDIBAPS Researcher, Tel. 932275400 (ext. 4543 and 4563). Email: PSERRA1@clinic.cat

Immunopathogenesis and therapeutic vaccines against HIV.
Dr. Montserrat Plana, IDIBAPS Researcher, Tel. 93 2275400 (ext. 2447 and 3144). Email: mplana@clinic.cat

Biomarkers of response to CAR-T therapy in multiple myeloma.

Dr. Carlos Fernández de Larrea, Physician Dept. of Hematology. Email: cfernan1@clinic.cat

Modulation of macrophage activity by nanoparticles in liver fibrosis.
Dr. Pedro Melgar, IDIBAPS Researcher and Massachusetts Institute of Technology (MIT), Tel. 93 4024524. Email: pmelgar@ub.edu

 

UB – Faculty of Pharmacy

Polyphenols and the immune system.
Dr. Margarida Castell, Professor of Immunology, Tel. 93 4024505. Email: margaridacastell@ub.edu  

Breast milk and the immune system.
Dr. Francisco J. Pérez-Cano, Associate Professor, Tel. 93 4024505. Email: franciscoperez@ub.edu
Dr. Àngels Franch, Associate Professor, Tel. 93 4024505 Email: angelsfranch@ub.edu
Modulation of the microbiota and immune system.
Dr. Malen Massot, Lecturer, Tel. 93 4024505. Email: malen.massot@ub.
Influence of diet on infectious and metabolic processes.
Dr. Maria José Rodríguez-Lagunas, Associate Professor, Tel. 93 4024505. Email mjrodriguez@ub.edu
 

UB – SJD Barcelona Children's Hospital

Study of immune system dysregulation disorders in children: from diagnosis to therapy.
Dr. Laia Alsina, Associate Professor, Head of the Allergy and Clinical Immunology Service, SJD Barcelona Children's Hospital and Hospital Clínic. Email: laia.alsina@sjd.es

 

UB - IDIBELL - Hospital de Bellvitge

New biological immunomodulators for the treatment of autoimmune diseases.
Dr. Josep M Aran, Researcher, Tel. 93 2607428. Email: jaran@idibell.cat



UB - Faculty of Medicine and Health Sciences - Hospital de Bellvitge

Nucleases in the function and dysfunction of the immune system.
Dr. Concepció Soler, Professor of Immunology, tel. 93 4039634. Email: concepciosoler@ub.edu

Immuno-oncolytic viruses for the treatment of cancer.
Dr. Juan José Rojas Expósito, Ramón y Cajal Researcher, Tel. 93 4039858. Email: jrojas@ub.edu

Immunity from non-immune cells.
Dr. Joan Manils, Lecturer Tel. 934039858. Email: joanmanils@ub.edu

IS Global – Campus Clínic

Immunology and/or vaccinology of malaria.
COVID-19. Natural immune response and vaccines
Dr. Carlota Dobaño, Researcher, Tel. 93 2275400 (ext. 4519). Email: Carlota.dobano@isglobal.org
Dr. Gemma Moncunill, Researcher, Tel. 93 2275400 (ext. 4569). Email: gemma.moncunill@isglobal.org

 

IBEC – Institute for Bioengineering of Catalonia

Migration of cytotoxic T lymphocytes in colorectal cancer.
Dr. Elena Martínez, Leading Group, Tel. 93 4039775. Email: emartinez@ibecbarcelona.eu
Dr. Maria García-Díaz, Researcher Tel. 93 4020543. Email: mgarcia@ibecbarcelona.eu

UAB - Campus/Institute of Biotechnology and Biomedicine (IBB)

Role of autoimmune regulator (AIRE) in antigenic processing and presentation during central tolerance.
Study of the different types of proteasome in tolerance and disease. Effect on the immunopeptidoma of MHC-I molecules.

Dr. Iñaki Álvarez, Associate Professor, Tel. 93 5813084. Email: Inaki.Alvarez@uab.cat

Effector T cells in breast cancer.
Dr. Mercè Martí, Full Professor, Tel. 93 5812801 Email: Merce.Marti@uab.cat

Mitochondrial dysfunction in the presentation of autoantigens and their role in the development of type 1 diabetes.
Dr. Carme Roura Mir, Associate Professor, tel. 93 5812801. Email: carme.roura@uab.cat

UAB – Faculty of Veterinary Medicine- Centre for Experimental Research in Animal Health (CRESA)

Immunology and development of vaccines against important pathogens in animal health and shared diseases (zoonosis).
Dr. Fernando Rodríguez, IRTA Researcher (CRESA), Tel. 93 5814562. Email: fernando.rodriguez@irta.cat
Dr. Jordi Argilaguet, IRTA Researcher (CRESA), Tel. Email: jordi.argilaguet@irta.cat

Immunology in canine, feline or equine leishmaniasis.
Dr. Laia Solano, Associate Professor, tel. 93 5818533. Email: laia.solano@uab.cat

 

UAB - Germans Trias i Pujol University Hospital - Germans Trias Research Institute (IGTP) and Carreras Foundation

Identification of biomarkers of response to immunotherapy in autoimmunity and cancer.
Neuroimmunology. Immunotherapy with tolerogenic dendritic cells in autoimmunity.
Tolerance in transplantation.
Dr. Eva Martínez Cáceres, Professor of Immunology, tel. 93 4978666. Email: emmartinez.germanstrias@gencat.cat
The immune system throughout life: Bases for personalized medicine.
Dr. Aina Teniente, Immunology Physician, Tel. 93 4978666 ext.3089. Email: ainatse@gmail.com
Biomarkers of immunoregulation in type 1
diabetes Dra. Marta Vives, Associate Professor, Biomedical Researcher, Tel. 93 5543050 (ext. 6380 or 6381). Email: mvives@igtp.cat
Evaluation of the immune response and host-pathogen relationships in the framework of clinical studies in tuberculosis.
Dr. Cristina Vilaplana, Associate Professor, Dept. of Microbiology, IGTP Foundation, Tel. 93 4978677. Email: cvilaplana@gmail.com
Transcriptional mechanisms that control normal hematopoiesis and leukemia.
Dr. Sergi Cuartero, Inves. Josep Carreras Research Institute, Tel. 93 5572800 ext. 4227. Email: scuartero@carrerasresearch.org
Role of CB1 endocannabinoid receptor signaling in macrophages in idiopathic pulmonary fibrosis.
Dr. Raquel Guillamat Prats, Miguel Servet Researcher, Tel. 93 5543050 (ext. 6411). Email: rguillamat@igtp.cat
Biology of resistance to immunotherapy in haematological tumours and solid tumours.
Dr. Enrique Arenas, Senior Associate Researcher, Email: earenas@carrerasresearch.org

UAB - Blood and Tissue Bank (BST)

Antiviral immunotherapy.
Dr. Francesc Rudilla, Specialist Physician, Tel. 93 5573500 (ext. 3646). Email: frudilla@bst.cat
Creation of immunological cell therapies from induced pluripotent stem cells (iPSCs).
Dr. Belén Álvarez, Cell Therapy Service, Blood and Tissue Bank, Tel. 93 5573505 (ext. 6717). Email: abalvarez@bst.cat
Typing HLA and other genes of interest for transplantation through the use of nanopore technology: Third Generation Sequencing.
Dr. M José Herrero, Specialist Physician, Tel. Tel. 34 93 5573500 (ext. 6745). Email: mherrero@bst.cat

UAB - Hospital de la Santa Creu i Sant Pau - Sant Pau Biomedical Research Institute (IIB Sant Pau)

Inflammatory processes and innate response.

Dr. Silvia Vidal, Associate Professor, Researcher, , Tel. 93 2919017. Email: svidal@santpau.es

Biomarkers in autoimmune diseases.

Dr. Laura Martínez, Specialist Physician, Associate Professor, Tel. 93 5537383 Email: lmartinezma@santpau.cat

Immunoregulation of the leukaemia cell.
Dr. Esther Moga, Associate Professor, Immunology Service, Tel. 93 5537384. Email: mmoga@santpau.cat

Inflammatory response in ischaemic stroke patients with carotid atherosclerosis.

Dr. Sonia Benítez. Tel. 93-5537595. Email: sbenitez@santpau.cat

Development of CD30 receptor-specific CAR-T cells for the treatment of classical Hodgkin lymphoma.

Dr. Laura Escribà. Email: LEscriba@santpau.cat

Autoimmune neuropathies. Immunological characterization.

Dr. Anaís Mariscal Rodríguez, Specialist Physician, Immunology Department, Tel. 93 5537385. Email: amariscal@santpau.cat

UAB - Vall d'Hebron University Hospital

Identification and characterization of autoantibodies in systemic sclerosis.

Dr. Roger Colobran, Associate Professor UAB, VHIR, Tel. 655 540347. Email: roger.colobran@uab.cat

Study of the pathogenesis and testing of new therapeutic approaches to Multiple Sclerosis.

Dr. Carmen Espejo, Tel. 934893599. Email: carmen.espejo@vhir.org

Immunological and epigenetic effects of rehabilitation in patients with Multiple Sclerosis.
Dr. Arnau Hervera, Ramón y Cajal Researcher, Clinical Neuroimmunology Group, VHIR. Tel. 93 4896844. Email: arnau.hervera@vhir.org

Design of immunotherapies for hematological neoplasms.

Dr. Marta Crespo Maull, Researcher, Tel. 932543450 (ext. 8667). Email: macrespo@vhio.net

Transcriptomic, epigenetic and functional characterization of patients with secondary hemophagocytic syndrome.

Dr. Mónica Martínez Gallo, Specialist Physician, Tel. 93 2746983. Email: monica.martinez.gallo@uab.cat

Research into new immunomodulatory therapies aimed at curing AIDS.
Dr. Maria J. Buzon, VHIR Researcher, Tel. 93 4894167. Email: mariajose.buzon@vhir.org

Tumor microenvironment and immune system in cancer.
Dr. Joan Seoane, ICREA Professor, Vall Hebron Institute of Oncology, VHIO, Tel. 93 2543450 (Ext. 8641). Email: jseoane@vhio.net

Identification of non-invasive biomarkers predictive of the diagnosis of microscopic colitis.

Dr. Ana María González. VHIR Researcher, Tel. 93 489 4035. Email: amgonzalez75@gmail.com

Immunology involved in transplant rejection and/or tolerance and opportunistic infections.

Dr. Oriol Bestard. Head of the Nephrology, Dialysis and Kidney Transplant Service, VHIR. Email: oriol.bestard@vallhebron.cat

UAB – Hospital Parc Taulí

Biomarkers of response to immunotherapy in pediatric patients with mite allergy.

Dr. Germà Julià, Specialist Physician, Clinical Laboratories Service, Tel. 649611394 (ext. 86163). Email: gjulia@tauli.cat

UPF - Department of Health and Life Sciences

Role of NK cells in the response to tumours.
Dr. Aura Muntasell, Researcher. Tel. 93 3160811. Email: amuntasell@imim.es

 

Municipal Institute of Medical Research (IMIM)-Hospital del Mar

Immunological mechanisms involved in the etiopathogenesis of chronic urticaria: regulatory factors for basophil and mast cell activation.
Dr. Ramon Gimeno, Researcher, Immunology Department. Email: rgimeno@imim.es

Modulation of the immune response by PARP proteins in cancer.
Dr. José Yélamos, Researcher, Tel. jyelamos@imim.es

Study of immunological mechanisms of kidney transplant rejection.
Dr. Marta Crespo Barrio, Head of the Nephrology Service. Tel. 93 2483162. Email: mcrespo@psmar.cat
Dr. Elisenda Alari, Senior Researcher. Email: elialari@gmail.com

Harvard University, EEU
Center for Stem Cell and Translational Immunotherapy (CSTI)

Development of new cellular immunotherapies for primary and metastatic tumors.
Dr. Khalid Shah, Professor Pathology and Experimental Therapeutics Department, Director of the Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, EEUU. Email: kshah@bwh.harvard.edu

Share:
LinkedIn
Twitter
Facebook
Email